Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Tamm, Q. Lu, A. Dugard, P. Eggimann, E. Mercier, E. Giamarellos, V. Gafner, H. Lazar, A. Perez, P. F. Laterre (Genf, Bern, Switzerland; Paris, Limoges, Tours, France; Athens, Greece; Brussels, Belgium). Panobacumab, a fully human monoclonal antibody for ventilator associated pneumonia caused by Pseudomonas aeruginosa. Eur Respir J 2010; 36: Suppl. 54, 5577

Member's Comments

No comment yet.

Related content which might interest you: Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model Source: Eur Respir J 2007; 29: 965-968 Year: 2007 Novel swine ARDS model induced by Pseudomonas aeruginosa pneumonia and VILI Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response Source: Eur Respir J 2007; 30: 1167-1172 Year: 2007 Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response Source: Eur Respir J, 53 (2) 1801891; 10.1183/13993003.01891-2018 Year: 2019 Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia Source: Eur Respir J 2007; 29: 548-560 Year: 2007 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors Source: Eur Respir J 2010; 35: 598-615 Year: 2010 Animal models of VAP Source: Eur Respir Mon 2011; 53: 98-112 Year: 2011 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005 An experience of moxifloxacin (MOX) use in therapy of nosocomial pneumonia (NP) in patients who hadn‘t risk factors to be infected by Pseudomonas aeruginosa Source: Eur Respir J 2005; 26: Suppl. 49, 187s Year: 2005 Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018 Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults. Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017